Conferences
ASCO GU 2016 Is NaF PET Ready to Replace Technetium for Clinical Care and Research? - Session Highlights
January 13, 2016
ASCO GU 2016 Integrative Clinical Genomics in Castration-Resistant Prostate Cancer - Session Highlights
January 12, 2016
ASCO GU 2016 The Incidence and Distribution of Lymph Node Metastases in Localized Prostate Cancer: Role of Imaging and Surgery - Session Highlights
January 12, 2016
ASCO GU 2016 Molecular Risk Stratification in Localized Prostate Cancer: Current Status and Unanswered Questions - Session Highlights
January 12, 2016
ASCO GU 2016 New Combined Clinical Risk (CCR) Score Aids in Active Surveillance Decision-making in Prostate Cancer - Session Highlights
January 11, 2016
ASCO GU 2016 Phase II Trial of Gemcitabine + Cisplatin + Ipilimumab in Patients With Metastatic Urothelial Cancer - Session Highlights
January 8, 2016
ASCO GU 2016 Active Surveillance: How to Measure, Manage, and Improve. - Poster Session Highlights
January 8, 2016
ASCO GU 2016 Urologists’ experiences with treatment of castration-resistant prostate cancer. - Poster Session Highlights
January 8, 2016
ASCO GU 2016 After the 2012 USPSTF Recommendation on Prostate Cancer Screening, Higher Gleason Grades and More Positive Cores
January 8, 2016